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Abstract
Introduction: Influence of the endogenous opioid system on the liver has not been studied enough. To understand the 
damaging effects of stress on the liver and the hepatoprotective effects of opioids, a study was performed on stress-re-
sistant and stress-susceptible animals.
Materials and methods: The investigation was performed on 725 Wistar male-rats. Various types of stress were mod-
eled: acute immobilization stress of various duration (3, 6 and 12 hours), chronic stress of limited mobility, swimming 
stress and traumatic stress (resection of 70% of the liver). Agonists of various types of opioid receptors in equimolar 
doses were injected to stressed animals at equimolar doses: DAGO – a mu-receptor agonist – at a dose of 6.3 mcg/kg, 
DSLET – a delta-receptor agonist – at a dose of 10 mcg/kg, and kappa receptor agonist dynorphin A (1-13) – at a 
dose of 20.1 mcg/kg.
Results and discussion: The stress-limiting action of the studied opioids is characterized by the reduced hepatocyte 
dystrophy, microcirculation correction, a decreased concentration of lipid peroxidation metabolites, a suppressed cy-
tolytic syndrome, a stimulated synthetic ability of the liver, and is more pronounced in stress- susceptible animals. 
The greatest stress-protective effect is shown after administering dynorphin A (1-13) in immobilization stress, and 
DAGO – in swimming stress. Dynorphin A (1-13) and DAGO manifested the most pronounced effect on the liver 
regeneration after resection. A preliminary stress simulation accelerates liver regeneration at the initial stage after re-
section.
Conclusion: The hepatoprotective effect of opioids in stress depends on the typological peculiarities of animals. The 
results obtained offer a challenge of synthesizing new hepatoprotectors.
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Introduction
Stress causes a disturbance in the homeostasis of the body, 
leading to changes in many organs and systems. Pertsov 
et al. (2015) determined the specific features of the res-
ponse of individuals to the action of the same stress sti-
muli. Based on numerous studies, the idea of individuals 
being stress-resistant and stress-susceptible was formula-
ted. It is generally recognized that the leading mechanism 
that determines the different resistance of animals and 
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people to stress is the functioning of stress-mediating and 
stress-limiting systems (Pshennikova 2003).
One of the target organs of stress is the liver. It was 
established that the development of stress was accompa-
nied by morphological and functional changes in the liver 
tissue (Lyashev and Serikov 2016, Serikov and Lyashev 
2015). The development of stress is accompanied by the 
inhibition of microsomal reductases, a disruption of hy-
droxylation, and disturbed synthesis of coenzymes.
One of the forms of emergency exposure is postoper-
ative stress, when a patient, along with traumatic tissue 
damage, has a stress response due to a combination of fac-
tors. However, carrying out massive liver resections is of-
ten accompanied by the development of a severe compli-
cation – post-resection liver failure (Mullen et al. 2007). 
Reducing the severity of post-resection complications is 
achieved by stimulating the recovery of the volume of 
functioning tissue, since it is known that liver tissue has a 
high regenerative activity (Mangnall et al. 2003).
A promising area of prevention and correction of 
stress-induced damage is the use of synthetic analogues 
of natural opioid peptides (OP). Currently, the endoge-
nous opioid system (EOS) is considered as the leading 
component of the anti-stress system of the body (Drolet et 
al. 2001, Lishmanov and Maslov 1994). The existence of 
at least 4 types of opioid receptors (OR) was established: 
mu, delta, kappa, ORLI (opioid like receptor), as well as 
subtypes: mu1, mu2-, mu3-, delta1- and delta2-, kappa1alfa-, 
kappa1betta-, kappa2-, kappa3-), for which selective ago-
nists were synthesized (Granier et al. 2012, Manglik et al. 
2012, Thompson et al. 2012, Wu et al. 2012). OPs having 
both a stress-limiting effect and a stimulating effect on re-
generation make it possible to use them in liver resection 
to accelerate regeneration.
The purpose of this investigation is to explain the 
mechanisms of the hepatoprotective action of endogenous 
opioid system (EOS) components during stress.
Materials and methods
Experimental studies were conducted on 725 Wistar male 
rats weighing 180–250 g each. The investigation was 
performed in compliance with the European Conven-
tion for the Protection of Vertebrate Animals Used for 
Experiments or for Other Scientific Purposes [Directive 
2010/63/EU]. All experimental studies were approved by 
the Ethics Committee of Kursk State Medical University, 
Ministry of Healthcare of the Russian Federation (proto-
col No1 of 28.05.2013). Vivisection was carried out in ac-
cordance with the ethical principles of treating laboratory 
animals and in compliance with the requirements of the 
“International recommendations for the conduct of bio-
medical research using animals” (1985).
In preliminary experiments, stress-resistant and 
stress-susceptible individuals were singled out from 
among the Wistar rat population in the open field test 
(Koplik 2002). The model of acute immobilization stress: 
fixation of an animal on its back on the laboratory table 
for 3, 6 or 12 hours. A two-hour swimming stress was 
modeled by placing the animal into a tank filled with wa-
ter at t=22 °C. The level of liquid was such that the animal 
could keep on the surface only by swimming.
Animals were removed from the experiment after 39 
hours, on the 4th and 7th days after completion of the stress 
simulation. The choice of these terms was based on the 
literature data that the period of 39 hours after stress corre-
sponds to the end of the anxiety stage (pathological chang-
es in the internal organs are most pronounced), the 4th day 
after the stress modeling is the beginning of the resistance 
stage; the 7th day – the maximum development of compen-
satory processes in the body (Vyborova et al. 2005).
To simulate chronic stress, long-term mobility restric-
tions were applied: for 12 days every day, from 9.00 am 
to 3 pm, the animals were placed into small-sized cells 
that restricted their mobility, without access to food and 
water (Neporada and Leont`eva 2003). The animals were 
removed from the experience on the 12th day.
The intensity of lipid peroxidation (LPO) was assessed 
by the concentration of the metabolites of these reactions 
in blood plasma and in the liver tissue homogenate: acyl-
hydroperoxides (AHPs) and malondialdehyde (MDA), as 
well as by the activity of antioxidant enzymes: superoxide 
dismutase (SOD) and catalase, which were assessed by 
traditional methods (Alekseev et al. 2013, Galaktionova 
et al. 1998).
The concentrations of total cholesterol (TC), triglyc-
erides (TG), the content of non-esterified fatty acids 
(NEFA), very low density lipoproteins (VLDL), low 
density lipoproteins (LDL) and high density lipoproteins 
(HDL) in plasma were determined by enzymatic colori-
metric methods.
The activity of alanine aminotransferase (ALT), as-
partate aminotransferase (AST), lactate dehydrogenase 
(LDH), the concentrations of total protein, albumin, glu-
cose, bilirubin in blood plasma were determined by tra-
ditional methods (Bais and Philcox 1994, Lorentz et al. 
1993, Menshikova 1987).
For morphological studies, paraffin blocks were made 
from liver fragments of the animals, using a standard tech-
nique. The slides were stained by hematoxylin and eosin. 
The following indicators were determined planimetrical-
ly: the percentage of normal and dystrophically-changed 
hepatocytes relative to the total number of cells, the de-
gree of dystrophic changes in the cytoplasm, the number 
of binuclear hepatocytes, the relative number of nuclei 
with one nucleolus, the diameter of nuclei of hepatocytes, 
and the specific volume of intrahepatic sinusoids.
Partial hepatectomy (PHE) was performed according 
to the method described by Higgins G.M. and Anderson 
R.M. (Higgins 1931). The animals were removed from 
the experiment on the 1st, 3rd, and 7th days of the experi-
ment. The total mass of the right and caudate lobes was 
determined, and the following indicators were calculated: 
1) a relative increase in the mass of the right and caudate 
lobes against the mass of these lobes after resection in 
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percent; 2) the relative mass of the liver (the ratio of the 
mass of the liver on the day of the study to the initial mass 
of the liver) in percent.
A median laparotomy was performed on the sham-oper-
ated rats, the liver was partially taken out of the abdominal 
cavity and then returned back. The laparotomy was sutured 
closed layer-by-layer. The animals were removed from the 
experiment within the same time periods as after PHE.
In the study, synthetic preparations of selective ago-
nists of individual OR classes:
DAGO is a selective mu-OR agonist (Sigma-Aldrich, 
USA). Structure: H-Tyr-D-Ala-Gly-N-methyl-Phe-Gly-ol.
DSLET is a selective delta-OR agonist (Vector+, No-
vosibirsk, Russian Federation). Structure: Н-Tyr-D-Ser-
Gly-Phe-Leu-Thr-ОН.
Dynorphin A (1-13) is a selective kappa-OR agonist 
(Vector+, Novosibirsk, Russian Federation). Structure: 
H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-
Lys-OH acetate salt.
The lack of a selective ORLI agonist is explained by 
the fact that peptide selective agonists of this OR type 
have not yet been established (Pasternak 2011).
The studied OPs were used in equimolar doses: 
DAGO – 6.3 μg per kg of body weight, DSLET – 10.0 
μg per kg of body weight, and dynorphin A (1-13) – 20.1 
μg per kg of body weight. These doses were chosen on 
the basis of the previous experiments by the authors and 
literature data on the high activity of OP in these doses 
(Lyashev 2002).
The drugs used were dissolved in physiological solu-
tion and administered intraperitoneally to rats in a volume 
of 0.2 ml daily for 5 days after modeling an acute immo-
bilization or swimming stress, and also intraperitoneally 
in a volume of 0.2 ml daily for 7 days from the 1st to the 
7th days of modeling chronic stress of limited mobility. 
To study the effect of OP on liver regeneration after PHE, 
the studied peptides were administered intraperitoneally 
to rats in a volume of 0.2 ml daily for 5 days after surgery. 
The control animals were similarly injected with physio-
logical solution.
The data obtained as a result of the research were pro-
cessed statistically, using parametric and non-parametric 
methods. The significance of differences in the mean val-
ues in the case of a normal distribution in two samples was 
evaluated by Student’s t-test, in the case of an abnormal 
distribution by Wilcoxon test. In order to identify hidden 
factors affecting statistical correlations, a factor analysis 
was carried out using the method of basic components. 
Statistical processing was performed using MS Excel and 
Statistica 10 software.
Results and discussion
Simulation of a 3-hour immobilization stress increased 
in the content of intermediate and final LPO metabolites 
in plasma only 39 hours after the end of exposure: the 
concentration of MDA increased 2.5 times (p<0.001), and 
of AHP – 2.6 times (p<0.001). There was an increase in 
SOD activity by 30.1% (p<0.01), while the activity of ca-
talase did not change significantly (p>0.05).
The injection of selective OR agonists brought about 
an antioxidant effect in the stressed rats. Catalase activity 
increased at all periods of the experiment compared with 
the control group (p<0.001). After 39 hours, the concen-
tration of MDA was significantly lower than that of the 
control group and, starting from the 4th day, it did not dif-
fer from that in the intact animals.
In the liver tissue, there was an increase in the content 
of MDA and AHP – by 75.3% and 60.3%, respectively, 39 
hours after the 3-hour immobilization (p<0.001). There 
was also an increase in the activity of the both studied 
antioxidant enzymes – SOD and catalase – by 41.6% and 
27.0%, respectively (p<0.001). After 4 days, there re-
mained a higher concentration of AHP in the liver tissue 
(by 34.9%, p<0.001) compared with that of the intact an-
imals (Table 1).
The use of OP had an inhibitory effect on LPO in the 
liver tissue of the stressed rats, which was manifested by 
a decrease in the concentration of MDA, but not of AHP 
(when injecting dynorphin A (1-13) – by 17.7%, DAGO 
– by 15.0%, DSLET – by 14.6% (p<0.001)) as early as 
39 hours after stress modeling. When using all OPs, an 
increase in catalase activity in the liver tissue was found 
39 hours after the exposure. An increase in SOD activity 
was established only with the use of DSLET (p<0.001) 
for all the periods of the experiment.
In the animals exposed to a 6-hour immobilization 
stress, there was an increase in the concentration of AHP 
in blood plasma – by 2.75 times (p<0.001) and of MDA – 
by 2.66 times (p<0.001) after 39 hours (Table 2). On the 
4th day, these disorders persisted. The changes in the ac-
tivity of antioxidant enzymes were multidirectional: cat-
alase activity decreased by 22.4% (p<0.001), while SOD 
activity, on the contrary, increased by 11.5% (p<0.05). 
Seven days after a 6-hour stress, the indicators did not 
significantly differ from those of the intact animals.
The use of OP reduced a degree of LPO activation and 
prevented a decrease in catalase activity. DSLET had the 
most pronounced stress-limiting effect, which was mani-
fested by a decrease in the concentration of LPO metabo-
lites, an increase in catalase activity (p<0.001) compared 
with those in the control group throughout all the periods 
of the experiment.
In liver tissue, a 6-hour stress was accompanied 39 
hours after by an increase in the content of MDA by 2.95 
times (p<0.001) and of AHP – by 2.57 times (p<0.001). 
The increased concentration of LPO metabolites re-
mained on the 4th and 7th days after immobilization (Ta-
ble 2). There was an increase in catalase activity was not-
ed: by 21.8% (p<0.05) and 20.4 % (p<0.01), on the 4th 
and 7th days, respectively. On the contrary, SOD activity 
decreased by 22.9% (p<0.01) on the 7th day, compared to 
that of the intact animals. The use of OP suppressed the 
activation of LPO and increased the activity of enzymes, 
especially SOD. Kappa-OR agonist dynorphin A (1-13) 
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had the most pronounced effect, which was manifested 
by a normalized content of AHP and a significant de-
crease in the concentration of MDA as early as on the 
4th day of the experiment. The peptide caused the most 
pronounced increase in SOD activity at all the periods of 
the experiment: after 39 hours – by 49.4%, on the 4th day 
– by 81.3%, and on the 7th day – by 2.6 times (p <0.001). 
Catalase activity was 30.4% (p<0.001) higher compared 
with that in the control group only on the 4th day. Under 
the influence of DAGO, the concentration of MDA de-
creased by 15.4% (p<0.01), and of DSLET – by 29.6% 
(p<0.001), of AHP – by 14.2% (p<0.05) and by 37.7% 
(p<0.001) after 39 hours, respectively, and remained sta-
tistically significantly lower compared with the control 
group. The use of DAGO did not affect the activity of 
catalase, whereas the peptide had an inhibitory effect 
on SOD activity 39 hours after exposure (by 10.8%, 
(p<0.05)), and a stimulating effect – by 36.5% (p<0.01) 
on the 7th day. The use of DSLET had a stimulating effect 
on catalase activity on the 4th day of the experiment, and 
on SOD – on the 4th and 7th days.
After a 12-hour immobilization, accumulation of lipid 
peroxidation metabolites in blood plasma of the stressed 
rats was observed throughout all periods of the experi-
Table 1. Effect of Opioid Peptides on the Concentration of Lipid Peroxidation Metabolites and the Activity of Antioxidant Enzymes 






Content of malonic 










Intact 17.4±0.4 6.3±0.3 21.1±0.9 23.1±1.1
Control (stressed) 39 hours 30.5±1.3ххх 10.1±0.4ххх 26.8±0.6ххх 32.7±0.7ххх
4 days 17.0±0.3 8.5±0.2ххх 21.3±0.9 25.0±0.8
7 days 18.0±0.4 6.1±0.3 20.7±1.2 23.9±0.9
Stress + dynorphin 
A (1-13) at a dose of 
20.1 mcg/kg
39 hours 25.1±0.9*** 9.0±0.4 30.1±0.5*** 32.2±0.8
4 days 16.6±0.3 5.8±0.3*** 21.2±0.7 23.4±0.7
7 days 16.5±0.4* 5.8±0.2 24.8±1.1* 20.5±1.4*
Stress+ DAGO at a 
dose of 6.3 mcg/kg
39 hours 25.6±0.3*** 8.0±0.2 28.7±0.5* 33.7±0.3
4 days 15.9±0.4 7.5±0.5 17.2±0.4** 17.5±0.5***
7 days 13.8±0.4*** 5.5±0.3 32.6±0.5*** 36.4±1.0***
Stress + DSLET at a 
dose of 10.0 mcg/kg
39 hours 25.7±0.3*** 8.4±0.3 29.8±0.6** 35.0±0.6***
4 days 15.9±0.4 6.2±0.4** 32.7±0.6*** 36.9±1.0***
7 days 15.4±0.6** 6.3±0.4 27.2±0.3*** 35.4±0.4***
Note: x – p<0.05, xx – p<0.01, xxx – p<0.001 compared with intact animals. * – p<0.05, ** – p<0.01, *** – p<0.001 compared with 
control animals.
Table 2. The Effect of Opioid Peptides on the Content of Lipid Peroxidation Metabolites and the Activity of Antioxidant Enzymes 
















Intact 17.4±0.4 6.3±0.3 21.1±0.9 23.1±1.0
Control (stressed) 39 hours 51.3±1.2ххх 16.2±0.7ххх 23.3±1.2 23.7±0.8
4 days 41.8±0.9ххх 9.7±0.5ххх 25.7±1.1х 21.9±1.1
7 days 32.8±0.7ххх 10.6±0.4ххх 25.4±0.8хх 17.8±0.7хх
Stress + dynorphin 
A (1-13) at a dose of 
20.1 mcg/kg
39 hours 27.6±0.4*** 9.3±0.6*** 19.7±2.4 35.4±1.2***
4 days 25.4±0.4*** 6.3±0.3*** 33.5±0.8*** 39.7±0.8***
7 days 17.5±0.3*** 6.2±0.3*** 21.6±1.9 46.3±0.6***
Stress+ DAGO at a 
dose of 6.3 mcg/kg
39 hours 43.2±0.5*** 13.9±0.9* 23.5±0.8 20.6±1.0*
4 days 37.8±0.5*** 8.7±0.3 23.7±1.2 23.8±0.9
7 days 25.6±0.4*** 8.0±1.0* 24.5±0.6 24.3±1.2**
Stress + DSLET at a 
dose of 10.0 mcg/kg
39 hours 36.1±0.6*** 10.1±0.7*** 25.9±0.5 25.6±0.8
4 days 27.5±0.5*** 9.1±0.6 33.2±0.7*** 38.4±1.2***
7 days 15.9±0.9*** 6.0±0.5*** 20.4±1.4 35.8±1.1***
Note: x – p<0.05, xx – p<0.01, xxx – p<0.001 compared with intact animals. * – p<0.05, ** – p<0.01, *** – p<0.001 compared with 
control animals.
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ment. Seven days after the 12-hour immobilization, the 
concentrations of both MDA and AHP exceeded similar 
values in the intact animals (MDA – by 68.0%, p<0.001; 
AHP – by 42.9%, p<0.05). There was a decrease in cat-
alase activity on the 7th day, but not of SOD. The use of 
all the studied OPs had an antioxidant effect in rats that 
exposed to a 12-hour immobilization stress. The most pro-
nounced effect was shown by a selective delta-OR agonist 
DSLET. By the 7th day, the content of LPO metabolites did 
not differ from that in the intact animals and was signifi-
cantly lower than that in the control group. The activity of 
antioxidant enzymes was significantly higher (p<0.001) 
compared with the control at all periods of the experiment.
In the liver tissue, the simulation of 12-hour stress was 
accompanied by the accumulation of MDA and AHP. 
SOD activity was reduced at all periods of the experiment, 
and catalase did not change significantly. The use of OP 
had a pronounced antioxidant effect. So, with the injec-
tion of DSLET, the concentration of MDA after 39 hours 
was 36.3% (p<0.001), and of AHP – by 52.3% (p<0.001) 
lower than those of the control animals. The activity of 
SOD and catalase significantly increased throughout all 
periods of the experiment (p<0.001). On the 7th day, the 
content of LPO metabolites did not differ significantly 
from that in the intact rats. The administration of dy-
norphin A (1-13) resulted in a decrease in the content of 
LPO metabolites in the liver tissue of rats throughout all 
periods of the experiment. SOD activity was higher than 
that in the control group at all stages of the experiment 
(47.1%, 52.0%, 76.9% higher than in the control group 
(p<0.001)). Catalase activity was higher compared with 
that in the control group only on the 4th and 7th days of the 
experiment (p<0.05 and p<0.01, respectively). When a 
selective mu-OR agonist DAGO was used, by the 7th day, 
the concentrations of MDA and AHP were significantly 
lower than those in the control group – by 34.0% and 
28.3%, respectively, and the AHP content did not differ 
significantly from that in the intact rats. By the 7th day, the 
activity of both antioxidant enzymes was higher than that 
in control rats: SOD – by 39.9% (p<0.001), and catalase 
– by 31.4% (p<0.01).
Simulation of a swimming stress was accompanied by 
an increased intensity of LPO in plasma and liver tissue 
of the experimental animals. Plasma concentration of in-
termediate and final LPO metabolites: AHP and MDA 
– increased by 125.0% and 39.3%, respectively (p<0.01-
0.001) 39 hours after the exposure (Table 3). The similar 
changes were also observed in the liver tissue: an increase 
in the content of AHP and MDA by 90.7% and 42.3%, 
respectively (p<0.001). On the 4th day of the experiment, 
there was normalization of concentrations of MDA and 
AHP in plasma and liver tissue (p>0.05). Swimming 
stress led to an 18.5% increase in SOD activity in plas-
ma 39 hours after the exposure (p<0.05). In liver tissue, 
SOD activity decreased over the same period by 14.7% 
(p<0.001), while catalase activity increased by 11.2% 
(p<0.05). By the 7th day, the indicators returned to normal 
(p>0.05). The injection of all the studied OPs had an anti-
oxidant effect. The most pronounced effect was observed 
when using the selective mu-OR agonist DAGO: the 
MDA content after 39 hours did not differ significantly 
from the similar indicator in the intact rats, and the AHP 
concentration, although being significantly higher than in 
the intact group, was 30.9% lower compared with that in 
the control animals (p<0.05). There was a 14.7% decrease 
in SOD activity (p<0.05), and catalase activity was higher 
than that in the intact group by 11.2% 39 hours after the 
simulation of swimming stress (p<0.05). By the 4th day, 
the activity of both enzymes did not differ from that of the 
intact rats. The use of DSLET or dynorphin A (1-13) also 
caused a decrease in the content of both MDA and AHP in 
blood plasma, but their effects were less pronounced. The 
injection of DAGO reduced the concentrations of MDA 
by 23.0% (p<0.001) and of AHP – by 29.4% (p<0.001) 
in the liver tissue compared with those the control group 
39 hours after the simulation of swimming stress. On the 
4th day of the experiment, the concentration of LPO me-
tabolites did not differ significantly from that in the intact 
rats (p>0.05). SOD activity remained almost unchanged 
throughout the experiment and was significantly high-
er than that in the control rats (p<0.001) and intact rats 
(p<0.001). After 39 hours, the catalase activity, on the 
contrary, was lower compared with that in the control (by 
30.1%, p<0.001) and intact (by 22.3%, p<0.001) rats. On 
the 4th and 7th days, it continued to increase. The use of 
DSLET and dynorphin A (1-13) also had an antioxidant 
effect, but the effect was less pronounced compared to 
that of DAGO.
Simulation of chronic stress of limited mobility was 
accompanied by a significant increase in the content of 
LPO metabolites in blood plasma and liver tissue. The 
concentration of MDA increased in plasma by 90.5%, and 
in liver tissue – by 106.0% (p<0.001). There was also a 
significant increase in the content of AHP (by 166.1% and 
158.3%, respectively, in plasma and liver, p<0.001). In 
control animals, a decrease in SOD activity was observed 
– by 44.3% in plasma and by 34.4% in the liver tissue 
(p<0.001). Catalase activity also reduced by 24.0% and 
26.8% in plasma and liver, respectively (p<0.001-0.01). 
The injection of the studied OPs had an inhibitory effect 
on the processes of LPO in blood plasma and liver tissue. 
The most pronounced antioxidant effect in plasma was 
produced by DAGO – there was a decrease in the content 
of MDA in blood plasma by 33.9% (p<0.001), of AHP – 
by 47.7% (p<0.001), whereas SOD activity increased in 
plasma by 54.4% (p<0.001). The activity of catalase in 
blood plasma did not change (p>0.05).
The administration of dynorphin A (1-13) led to the 
most pronounced antioxidant effects in liver tissue: the 
concentration of MDA decreased by 38.6% (p<0.001), 
and of AHP – by 31.5% (p<0.01) (Fig. 1). SOD activi-
ty increased by 29.9% (p<0.001), and catalase activity 
increased by 24.9% (p<0.05). Only the injection of dy-
norphin A (1-13) resulted in a 15.6% increase of cata-
lase activity in plasma compared with that in the control 
group (p<0.05).
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The study found that all the studied OPs manifest anti-
oxidant activity, which was expressed by a decrease in the 
content of intermediate and final LPO metabolites: AHP 
and MDA – in blood plasma and liver tissue under the 
action of various stress factors. At the same time, some 
patterns of the peptides effect were established. It was 
shown that when simulating acute immobilization stress, 
the use of a selective delta-OR agonist DSLET had the 
most pronounced effect on the content of MDA and AHP 
in blood plasma. Thus, it was established that in the ani-
mals that had been injected with this peptide on the 4th day 
after immobilization the concentrations of MDA and AHP 
did not significantly differ from those in the intact rats. 
On the 4th day, in the animals that had been exposed to a 
12-hour stress, the content of MDA did not significantly 
differ from the concentration of this substance in the in-
tact group, either.
The most active antioxidant inhibiting the enhance-
ment of LPO processes in the liver tissue was dynorphin 
A (1-13). The injection of this peptide to rats that had been 
exposed to 6-hour, 12-hour immobilization or swimming 
stress, the normalization of the concentration of AHP in 
the liver tissue was observed as early as on the 4th day af-
ter simulating the stress compared with the control group.
Among the studied OPs, DAGO exhibited the greatest 
antioxidant activity under swimming stress. The concen-
tration of the LPO final product was significantly lower 
than that in the control group and did not differ from this 
indicator in the intact rats, both in the liver tissue and in 
blood plasma 39 hours after stress simulation. The con-
tent of AHP was also significantly lower compared with 
that in the control group. Some patterns of selective OR 
agonists influencing the activity of antioxidant enzymes: 
SOD and catalase – under various types of stress were 
also established. The effects of drugs depended on the na-
ture of the stress exposure and the observation time.
Thirty-nine hours after an acute 6-hour immobiliza-
tion stress in stress-resistant rats, there was a 2.03-time 
increase in the number of dystrophically-changed hepat-
ocytes (p<0.001) and a 10.3% decrease in the specific 
content of normal cells (p<0.001) (Fig. 2). A 3.25-time 
increase in the specific area of dystrophically-changed 
sections of the cytoplasm (p<0.001) is also shown. A 
34.6% increase in the proportion of binuclear hepatocytes 
(p<0.001) and a 4.4% decrease in the proportion of nu-
clei with one nucleolus (p<0.05) indicate the activation of 
reparative processes in the liver tissue. Disorders of mi-
crocirculation in liver tissue were manifested by a 77.4% 
increase in the total volume of sinusoids (p<0.001). On 
the 4th day of the experiment, the number of dystrophical-
ly-changed cells remained elevated (by 82.4% compared 
with that in the intact group, p<0.001), and the number of 
Table 3. Effect of Opioid Peptides on the Content of Malondialdehyde and Acyl Hydroperoxides, Activity of Antioxidant Enzymes 






Content of malonic 










Intact 16.8±0.6 5.89±0.30 19.7±0.4 30.7±0.5
Control (stressed) 39 hours 23.9±0.6ххх 11.23±0.32ххх 21.9±0.5х 26.2±0.3ххх
4 days 17.4±0.8 5.78±0.30 21.5±0.5х 25.9±0.5ххх
7 days 18.4±0.7 5.39±0.26 19.5±0.6 30.7±1.3
Stress + dynorphin 
A (1-13) at a dose of 
20.1 mcg/kg
39 hours 21.2±0.6*** 7.85±0.34*** 22.6±0.6 32.0±0.5***
4 days 16.0±0.3 5.49±0.32 22.5±0.4 27.3±0.5
7 days 15.30±0.3** 5.45±0.23 17.8±0.3* 34.6±0.4*
Stress+ DAGO at a 
dose of 6.3 mcg/kg
39 hours 18.1±0.5*** 7.93±0.24*** 15.3±0.3*** 34.9±0.4***
4 days 15.4±0.4 4.87±0.08* 25.7±0.6*** 34.2±0.8***
7 days 15.6±0.2** 5.15±0.20 34.8±0.5*** 34.2±0.4*
Stress + DSLET at a 
dose of 10.0 mcg/kg
39 hours 19.2±0.4*** 7.71±1.56*** 25.2±0.5** 35.1±0.4***
4 days 16.0±0.4 4.93±0.34 22.5±0.4 27.5±1.3
7 days 15.4±0.2** 5.32±0.17 17.4±0.6* 32.6±0.4
Note: x – p<0.05, xx – p<0.01, xxx – p<0.001 compared with intact animals. * – p<0.05, ** – p<0.01, *** – p<0.001 compared with 
control animals.
Figure 1. The effect of opioid peptides on the content of lip-
id peroxidation metabolites in rat liver tissue after modeling 
chronic stress. Note: xxx – p<0.001 compared with intact ani-
mals. * – p<0.05, ** – p<0.01, *** – p<0.001 compared with 
control animals.
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normal cells decreased (by 8.3%, p<0.001). The specific 
volume of dystrophically-changed sections of the cyto-
plasm was 2.5 times higher than this indicator in the intact 
group (p<0.001). The share of binuclear hepatocytes was 
20.6% higher compared with the previous observation 
period, which reflects intensification of regenerative pro-
cesses. The total number of sinusoids was 31.0% higher 
(p<0.001) as compared with that in the intact rats. On the 
7th day, all the studied parameters did not differ signifi-
cantly from those in the intact rats.
Simulation of a 6-hour immobilization stress for 
stress-susceptible rats led to a 92.8% increase in cells 
with dystrophic changes in the cytoplasm (p<0.001) and 
an 11.6% decrease in the proportion of normal hepato-
cytes (p<0.001). There was a 39.5% increase in the share 
of binuclear hepatocytes (p<0.01) and a 6.8% decrease 
in the number of hepatocytes, in the core of which one 
nucleolus was detected (p<0.01). The total number of si-
nusoids was statistically significantly higher (by 54.9%, 
p<0.001) than that in the intact rats of this group. Four 
days after stress simulation, the proportion of cells with 
dystrophic changes in the cytoplasm was significantly 
higher than that in the intact stress-susceptible animals 
(by 62.2%, p<0.001), and the number of normal hepat-
ocytes was lower than that in the intact group (by 7.8%, 
p<0.001). The specific volume of dystrophically-changed 
cytoplasm was 3.0 times higher than that in the intact 
group (p<0.001). There was a significant increase in the 
share of binuclear hepatocytes compared with that in the 
previous experimental period (by 22.0%) (p<0.001). On 
the contrary, although the number of hepatocytes with one 
nucleolus increased, however, it was lower than that of the 
intact stress-susceptible animals (by 4.3%, p<0.01). Over 
that period, the total number of sinusoids also remained 
higher than that in the intact rats (by 30.8%, p<0.01). On 
the 7th day, like in the group of stress-resistant animals, no 
indicators differed significantly from those of the intact 
animals of this group.
The injection of the studied OPs to stress-resistant rats 
had no significant impact on either the number of normal 
and dystrophically-changed hepatocytes, or the specific 
volume of dystrophically-changed sections of the cyto-
plasm. However, all the studied peptides caused a de-
crease in the total number of sinusoids compared to that 
in the control group 39 hours after simulating a six-hour 
immobilization stress: dynorphin A (1-13) – by 14.1% 
(p<0.05), DAGO – by 12.8% (p<0.05), and DSLET – by 
15.4% (p<0.05). It was found that regenerative processes 
intensified in the liver parenchyma under the influence of 
opioids in stress-resistant rats exposed to 6-hour immobi-
lization stress.
Injection of dynorphin A (1-13) caused an increase in 
the number of binuclear hepatocytes by 25.7% (p<0.001), 
DAGO – by 34.3% (p<0.001), DSLET – by 28.0% 
(p<0.001), while a decrease in the proportion of hepat-
ocytes containing one nucleolus was 5.5% when using 
dynorphin A (1-13), 5.4% – DAGO, and 4.6% – DSLET 
(p<0.05) compared with that in the control group (Fig. 3). 
After 4 days, a decrease in the total number of sinusoids 
was observed only in the group of rats that had been treat-
ed with dynorphin A (1-13) (by 17.3%, p<0.05). The use 
of DAGO or DSLET did not cause significant changes in 
this indicator. No intensification of regenerative process-
es in the groups treated with OP was observed compared 
with the control group over that period. In the group of 
stress-resistant rats which had been exposed to a 6-hour 
immobilization stress and which had been injected with 
dynorphin A (1-13), the share of binuclear hepatocytes 
increased by 52.9%, when using DAGO – by 56.5%, and 
DSLET – by 60.1% (p<0.001).
The use of the studied OPs in stress-susceptible rats 
which had been exposed to a 6-hour immobilization stress 
also did not significantly affect the number of normal 
hepatocytes and the number of dystrophically-changed 
hepatocytes compared with the control group, either. 
However, the specific volume of dystrophically-changed 
Figure 2. Dystrophic changes of hepatocytes in animals 39 hours after 6-hour immobilization stress. Note: stained with hema-
toxylin and eosin. A – stress-resistant rats, control group: small number of dystrophically-changed hepatocytes, the 
heterogeneity of the cytoplasm of cells is poorly expressed. × 140. B – stress-susceptible rats, control group: numerous 
dystrophically-changed hepatocytes, the heterogeneity of the cytoplasm of cells is well expressed. × 140.
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cytoplasm was statistically significantly lower: when us-
ing dynorphin A (1-13) – by 38.1%, DAGO – by 33.3%, 
and DSLET – by 30.0% (p<0.001). There was a decrease 
in the total number of sinusoids in the groups that had 
been injected with the opioids under study: when using 
dynorphin A (1-13) or DSLET – by 13.7% (p<0.05). The 
injection of DAGO did not have a significant effect on 
this indicator in the stress-susceptible individuals. Inten-
sification of regenerative processes under the influence 
of opioids in the liver tissue of the stress-susceptible rats 
which had been exposed to an immobilization stress was 
confirmed by an increased number of binuclear hepato-
cytes: with the injection of dynorphin A (1-13) – by 17.9% 
(p<0.05), DAGO – by 23.1% (p<0.05), and DSLET – by 
24.9% (p<0.01) (Fig. 3). However, there was no increase 
in the proportion of hepatocytes containing a single nucle-
olus in the opioid groups compared with that in the con-
trol animals. On the 4th day of the experiment, there was 
only a decrease in the total volume of sinusoids with the 
injection of the peptides: dynorphin A (1-13) – by 16.8% 
(p<0.05), DAGO – by 16.0% (p<0.05), and DSLET – by 
15.1% (p<0.05).Like in the group of stress-resistant an-
imals, on the 7th day of the experiment, there was an in-
crease in the number of binuclear cells in stress-suscepti-
ble rats, which had been injected with the studied opioids: 
when using dynorphin A (1-13) – by 36.2%, DAGO – by 
40.9%, and DSLET – by 44.3% (p<0.001).
Thus, the study found that simulating six-hour immo-
bilization stress for stress-resistant and stress-susceptible 
rats was accompanied by the development of dystrophic 
changes in hepatocytes, impaired microcirculation in the 
liver tissue, activation of regenerative processes in the pa-
renchyma of the organ as early as 39 hours after the start 
of the experiment. Only on the 7th day of the experiment, 
the studied parameters returned to normal. Dystroph-
ic changes in hepatocytes were more pronounced in the 
stress-susceptible animals, which was manifested by an 
increase in the specific volume of dystrophically-changed 
sections of the cytoplasm.
When studying the effect of selective OR agonists on 
the morphological abnormalities in the liver in rats that 
had been exposed to a 6-hour immobilization stress, it was 
found that all the opioids studied had a protective effect, 
which was manifested by a decrease in the total number 
of sinusoids and intensification of regenerative processes 
in the liver parenchyma both in the group of stress-resist-
ant and stress-susceptible animals. In stress-susceptible 
rats, there was also a decrease in the specific volume of 
dystrophically-changed cytoplasm when administering 
peptides. There were no significant differences in the ef-
fects of selective agonists of individual classes of OR.
In stress-resistant animals, simulation of long-term 
mobility restriction stress resulted in a 13.9% decrease 
in the proportion of normal hepatocytes and a 79.9% 
increase in the number of dystrophically-changed cells 
in the cytoplasm (p<0.001). The dystrophic changes in 
the cytoplasm were also more pronounced, which was 
manifested by a 4.8-time increase in the cytoplasmic 
vacuolization index (p<0.001). Dystrophy of cells was 
manifested by heterogeneity of the cytoplasm due to its 
hydration and vacuolization of the cytoplasmic reticulum, 
and an impaired structure of the plasma membrane. The 
total number of sinusoids increased by 44.0% (p<0.01) 
(Fig. 4). Kupffer cells lining sinusoids were round, with 
swollen cytoplasm.
In stress-resistant rats, the development of regenerative 
processes was observed in the parenchyma of the organ. 
This was manifested by a 21.7% increase in the average 
volume of nuclei in rats that had been exposed to stress 
(p<0.01). There was a significant 19.3% decrease in the 
number of cells, the nucleus of which had only one nucle-
olus (p<0.001). The proportion of binuclear hepatocytes 
increased by 19.5% (p<0.05).
The changes that develop in liver tissue in stress-sus-
ceptible animals when simulating chronic stress have a 
similar direction, but are much more pronounced.
Injection of dynorphin A (1-13) to stress-resistant an-
imals prevented the development of dystrophic chang-
Figure 3. Binuclear hepatocytes in animals 4 days after 6-hour immobilization stress. Note: stained with hematoxylin and eosin 
stain. A – stress-susceptible rats, control group: small number of binuclear hepatocytes. × 280. B – stress-susceptible rats treated 
with dynorphin A (1-13): the number of binuclear hepatocytes is significantly higher. × 280.
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es in the liver parenchyma, which was manifested by a 
22.4% decrease in the number of dystrophically-changed 
hepatocytes (p<0.01). The number of normal hepatocytes 
also increased by 8.8% (p<0.01). The specific area of 
dystrophically-changed sections of the cytoplasm reduced 
by 37.5% (p<0.05). Dynorphin A (1-13) had no effect on 
vascular changes in the liver parenchyma. Activation of 
regenerative processes under the influence of dynorphin A 
(1-13) in stress-resistant rats was manifested by a 13.3% 
decrease in the number of cells whose nucleus contained 
only one nucleolus (p<0.01), as well as by a 17.2% in-
crease in the share of binuclear hepatocytes (p<0.05). The 
use of DAGO in stress-resistant rats led to a 11.6% de-
crease in the proportion of dystrophically-changed hepat-
ocytes (p<0.05) and a 5.1% increase in the number of nor-
mal cells (p<0.05). The use of DSLET did not affect the 
studied parameters.
The injection of all studied opioids led to a decrease in 
the severity of destructive disorders and increased regen-
erative processes in the liver parenchyma of stress-sus-
ceptible rats that had been exposed to stress. The most 
active hepatoprotector was dynorphin A (1-13). The use 
of this drug led to a 31.6% decrease in the number of 
dystrophically-changed hepatocytes (p<0.001), a 22.4% 
increase in the proportion of normal cells (p<0.001), and 
a 33.3% decrease in the specific area of the dystrophical-
ly-changed sections of the cytoplasm (p<0.01). Activa-
tion of regenerative processes was manifested by a 30.4% 
increase in the average size of hepatocyte nuclei (p<0.01), 
as well as by a 20.0% decrease in the proportion of cells 
with only one nucleolus in the nucleus (p<0.001).
The use of DAGO or DSLET in stress-susceptible 
rats that had been exposed to a prolonged stress had a 
protective effect on the liver cells and stimulated the re-
generative processes in the parenchyma. When inject-
ing DAGO, there was a 13.5% increase in the number 
of normal hepatocytes (p<0.01), a 19.0% decrease in the 
proportion of dystrophically-changed cells (p<0.01), and 
a 41.2% decrease in the specific proportion of dystroph-
ically-changed sections of the cytoplasm (p<0.01). 
A 13.6% increase in the proportion of binuclear hepato-
cytes (p<0.05) and an 11.8% decrease in the proportion 
of cells with only one nucleolus in the nucleus (p<0.01) 
indicated the activation of regenerative processes in the 
parenchyma of the liver under the influence of the pep-
tide. Unlike stress-resistant rats, the injection of DSLET 
to stress-susceptible rats also led to a 15.9% decrease 
in the number of dystrophically-changed hepatocytes 
(p<0.05), an 11.3% increase in the proportion of normal 
cells (p<0.05), and a 33.3% decrease in the specific the 
area of  dystrophically-changed sections of the cytoplasm 
(p<0.01). The effect of this peptide on regeneration was 
significantly lower than that of other opioids. There was 
recorded only a 7.3% decrease in the proportion of cells 
whose nucleus contained one nucleolus (p<0.05).
It was established that in the rats that had been exposed 
to chronic stress, like when simulating an acute immobi-
lization stress, there were both manifestations of liver tis-
sue damage and manifestations of tissue regeneration. The 
changes in liver tissue damage were more pronounced in 
the stress-susceptible animals.
The studied OPs had a stress-limiting hepatoprotective 
effect, leading to a decrease in dystrophic changes in the 
liver tissue and activation of reparative processes. The 
most pronounced hepatoprotective effect in both acute 
and chronic stress was shown by selective kappa-OR ag-
onist dynorphin A (1-13).
The investigation did not establish statistically signif-
icant differences in the effects of various types of stress 
on the biochemical parameters in stress-resistant and 
stress-susceptible rats, so the data are presented for the 
entire group of animals.
Simulating an acute 3-hour stress led to an increase in 
AST activity by 32.6% (p<0.001) and in ALT – by 49.4% 
(p<0.001) 39 hours after the end of immobilization. As 
early as on the 4th day of the experiment, AST and ALT 
activity returned back to normal in blood plasma of the 
experimental animals. In the rats that had been exposed 
to an acute 6-hour immobilization stress, there was a 
2.51-time increase in AST activity (p<0.001) and a 2.67-
Figure 4. Expansion of the intrahepatic sinuses in animals after chronic limited mobility stress. Note: stained with hematoxylin and 
eosin. A – stress-susceptible rats, control group: significant expansion of the intrahepatic sinuses. × 280. B – stress-resistant rats, 
control group: the expansion of the intrahepatic sinuses is less pronounced. × 280.
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time increase – in ALT (p<0.001) only 39 hours after the 
experiment (Table 4). There was a 5.0% decrease in the 
total protein content (p<0.05). Acute 12-hour immobili-
zation stress was accompanied by a 2.69-time increase 
in AST activity and a 2.85-time increase in ALT activity 
(p<0.001) 39 hours after the end of exposure. It was also 
established that the concentration of total protein in blood 
plasma decreased by 5.3% (p<0.05). On the 4th day after 
the stress exposure, the AST and ALT activities remained 
elevated (by 27.0% and 34.5%, respectively, p<0.01) 
compared to those in the intact rats. There was a 7.8% 
decrease in the albumin content (p<0.05). On day 7th, all 
the studied parameters in the intact and control groups did 
not differ.
The use of all the studied OPs reduced the severity of 
cytolytic syndrome, which was manifested by lower val-
ues of AST and ALT activity, in case of immobilization 
of various duration. In the rats which had been exposed 
to a 3-hour or 6-hour immobilization stress the most pro-
nounced anti-stress effect was observed with the use of 
selective agonists of kappa and delta-OR dynorphin A (1-
13) and DSLET.
The use of a selective mu-OR agonist DAGO at a 
dose of 6.3 µg/kg in a 6-hour stress also caused a de-
crease in the activities of AST and ALT compared 
with those in the control group, but to a lesser extent 
than with dynorphin A (1-13) or DSLET: AST activi-
ty decreased by 18.5% (p<0.01) and ALT – by 28.7% 
(p<0.01). The use of DAGO also prevented a decrease 
in the total protein content in blood plasma 39 hours 
after stress simulation.
Simulation of swimming stress was accompanied by 
an increase in AST activity in blood plasma by 13.9% 
(p<0.01) only 39 hours after the stress modeling. The 
use of OP DSLET and dynorphin A (1-13) had a hepato-
protective effect, which was manifested by a decrease in 
AST activity 39 hours after the simulation of swimming 
stress by 17.7% and 19.2%, respectively (p<0.001). At 
the same time, AST activity was not different from that 
of the intact rats. On the 4th and 7th days of the experiment, 
there were no differences in all the studied parameters 
between the control rats and the animals that had been 
injected with OP.
Simulation of the twelve-day limited mobility stress 
was accompanied by the development of cytolytic syn-
drome and impaired protein-synthetic liver function (Ta-
ble 5). Thus, AST activity in blood plasma increased 2.5 
times (p<0.001) and ALT – 3.3 times (p<0.001). There 
was a decrease in the content of total protein by 5.0% 
(p<0.01) and albumin – by 9.0% (p<0.001).
The use of OPs prevented the suppression of pro-
tein-synthetic liver function, which was manifested by 
the absence of differences between the values of the in-
dicators of total protein and albumin in the group of the 
intact rats and stressed animals that had received OPs. All 
the studied peptides reduced the severity of cytolytic syn-
drome: for instance, with the injection of dynorphin A (1-
13), AST activity decreased by 33.5% (p<0.001) and ALT 
– by 48.6% (p<0.001). DSLET and DAGO had a similar 
effect: the use of DSLET was accompanied by a decrease 
in AST activity by 25.4% (p<0.001) and ALT – by 45.7% 
(p<0.001), and the use DAGO resulted in a decrease in 
AST by 17.4% (p<0.01) and ALT – by 17.5% (p<0.05).
Thus, it was found that the use of OPs reduced the se-
verity of cytolytic syndrome and prevented the disorders 
of the protein-synthetic function of the liver in the animals 
which had been exposed to an acute or chronic stress.
Simulation of acute immobilization stress was accom-
panied by an increase in the concentrations of TC, TG, 
LDL, VLDL, NEFA 39 hours after the end of immobiliza-
tion compared with those in the intact animals (Table 6). 
On the 7th day after the immobilization simulation, no sta-
tistically significant differences in the studied parameters 
were found between the intact group and the animals that 
had been exposed to 3- or 6-hour stress. In the rats that 
had been exposed to a 12-hour stress, the concentration 
of TC was significantly lower compared with that in the 
intact animals (by 20.9%, p<0.01).
The use of OPs in the rats that had been exposed to 
3-hour immobilization led to a decrease in the concen-
trations of TG, LDL, NEFA only 39 hours after the end 
of stress compared with those in the control group. For 
instance, the decrease in TG concentration when admin-
istering DAGO was by 27.0% (p<0.001), DSLET – by 
30.4% (p<0.001), and dynorphin A (1-13) – by 29.6% 
(p<0.001). The decrease in the content of LDL in all 
groups that had been injected with peptides was the same 
– by 28.6% (p<0.05). The decrease in the concentration of 
NEFA was the following: when using DAGO or DSLET 
– by 28.4% (p<0.01), and when using dynorphin A (1-13) 
– by 33.1% (p<0.01). The increase in HDL concentration 
in rats treated with DAGO was 39.3% (p<0.01), and with 
dynorphin A (1-13) – 42.9% (p<0.01).
In the animals that had been exposed to a 6-hour sim-
ulated stress, 39 hours after the application of DAGO 
or DSLET, there was found a decrease in the contents 
of the following: TC – by 21.2% and 18.6%, respec-
tively (p<0.01), TG – by 23.2% and 21.0% respectively 
(p<0.05), and NEFA – by 15.0% and 20.3%, respectively 
(p<0.05). In both groups, there was also an increase in 
HDL concentration: with the injection of DAGO – 3.2 
times, and of DSLET – 4.9 times (p<0.001). In the group 
treated with dynorphin A (1-13), a decrease in the content 
of NEFA was observed – by 20.9% (p<0.05), as well as a 
4.2-time increase in HDL (p<0.001). On the 4th day, there 
was a decrease in TG by 16.1%, 15.6% and 17.4%, as well 
as a decrease in NEFA by 26.8%, 34.1% and 30.1% in all 
the experimental groups, which had been injected with 
the investigated OPs: DAGO, DSLET or dynorphin A (1-
13), respectively (p <0.05-0.01). There was an increase in 
the concentration of HDL only in the groups that had been 
injected with DAGO (by 35.5%, p<0.05) or DSLET (by 
25.0%, p<0.05). On the 7th day after simulating the 6-hour 
immobilization stress, there was a decrease in the levels 
of VLDL and LDL and an increase in the concentration of 
in all the groups receiving OPs.
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Table 4. The Effect of 6-hour Immobilization Stress on the Content of ALT and AST in Blood Plasma of Rats (M±m, n=8).
Indicator
Group
Period after stress simulation Aspartate aminotransferase, un/L Alanine aminotransferase, un/L
Intact 193.0±11.6 53.4±3.3
Control (stressed) 39 hours 484.8±18.8ххх 142.5±10.8ххх
4 days 213.4±10.3 54.8±2.5
7 days 206.6±19.7 52.8±5.2
Stress+ DAGO at a 
dose of 6.3 mcg/kg
39 hours 395.1±8.8** 101.6±3.5**
4 days 195.4±5.2 57.4±2.1
7 days 199.8±12.2 47.8±1.6
Stress + DSLET at a 
dose of 10.0 mcg/kg
39 hours 303.5±13.1*** 92.1±3.2***
4 days 201.5±6.3 55.9±2.2
7 days 198.4±8.8 51.4±1.3
Stress + dynorphin 
A (1-13) at a dose of 
20.1 mcg/kg
39 hours 298.5±11.1*** 80.8±2.4***
4 days 198.4±6.4 55.6±2.5
7 days 203.0±12.5 54.6±2.1
Note: x – p<0.05, xx – p<0.01, xxx – p<0.001 compared with intact animals. * – p<0.05, ** – p<0.01, *** – p<0.001 compared with 
control animals.
Table 5. The Effect of Chronic Stress on the Activity of ALT and AST in Blood Plasma of Rats (M±m, n=8).
Indicator
Group
Aspartate aminotransferase, un/L Alanine aminotransferase, un/L
Intact 205.8±5.1 56.0±2.4
Control (stressed) 518.9±12.4ххх 184.1±9.2ххх
Chronic stress+ DAGO at a dose of 6.3 mcg/kg 428.8±11.7** 151.9±7.4*
Chronic stress + DSLET at a dose of 10.0 mcg/kg 386.9±13.0*** 99.9±5.9***
Chronic stress + dynorphin A (1-13) at a dose of 
20.1 mcg/kg
344.9±9.0*** 94.5±4.0***
Note: x – p<0.05, xx – p<0.01, xxx – p<0.001 compared with intact animals. * – p<0.05, ** – p<0.01, *** – p<0.001 compared with 
control animals.
Table 6. The Effect of Opioid Peptides on the Content of Lipoproteins of Different Density in Blood Plasma of Rats at Different 
Periods After 6-hour Immobilization (M±m, n=8).
Indicator
Group
Period after stress 
simulation
LPVLD, mmol/L LPLD, mmol/L LPHD, mmol/L
Intact 0.07±0.01 0.06±0.01 0.14±0.01
Control (stressed) 39 hours 0.14±0.01 ххх 0.14±0.01ххх 0.14±0.02
4 days 0.08±0.01 0.06±0.01 0.40±0.03 ххх
7 days 0.09±0.01 0.08±0.01 0.15±0.02
Stress+ DAGO at a 
dose of 6.3 mcg/kg
39 hours 0.12±0.01 0.13±0.01 0.45±0.05***
4 days 0.10±0.01 0.08±0.01 0.54±0.03*
7 days 0.06±0.01* 0.05±0.01* 0.37±0.02***
Stress + DSLET at a 
dose of 10.0 mcg/kg
39 hours 0.13±0.01 0.14±0.01 0.69±0.04***
4 days 0.05±0.01 0.04±0.01 0.50±0.02*
7 days 0.06±0.01* 0.05±0.01* 0.43±0.04***
Stress + dynorphin 
A (1-13) at a dose of 
20.1 mcg/kg
39 hours 0.15±0.01 0.14±0.01 0.59±0.04***
4 days 0.06±0.01 0.04±0.01 0.44±0.02
7 days 0.05±0.01* 0.04±0.01* 0.50±0.03***
Note: x – p<0.05, xx – p<0.01, xxx – p<0.001 compared with intact animals. * – p<0.05, ** – p<0.01, *** – p<0.001 compared with 
control animals.
Thirty-nine hours after 12-hour immobilization in the 
groups that had been treated with the studied OPs, there 
was a decrease in the TC and TG contents in comparison 
with those in the control group. For instance, the concen-
tration of TC decreased by 22.6% (p<0.001), and of TG – 
by 18.8% (p<0.01) in the group that had been treated with 
DAGO. The use of DSLET and dynorphin A (1-13) was 
accompanied by a drop in the content of not only TC and 
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TG, but also of NEFA: when using DSLET – by 20.2% 
(p<0.001), 13.1% (p<0.05) and 19.1% (p<0.05), respec-
tively, and when using dynorphin A (1-13) – by 22.6% 
(p<0.001), 18.8% (p<0.001) and 22.1% (p<0.05), respec-
tively, compared with those in the control group.
There were no changes in the concentration of VLDL 
and LDL, while the content of HDL significantly increased 
– 2.2 times (p<0.01), 2.4 times (p<0.001) and 3.1 times 
(p<0.001), respectively, when using DAGO, DSLET or 
dynorphin A (1-13). On the 4th day after the simulation 
of the 12-hour immobilization stress, the concentrations 
of TG and NEFA were significantly lower compared with 
those in the control group in all the groups, which had 
been given OPs. In the rats treated with DAGO, the de-
crease was by 21.1% and 26.2% (p<0.05, p<0.01), with 
DSLET – by 29.8% and 33.8% (p<0.01), and with dynor-
phin A (1-13) – by 25.2% and 34.6% (p<0.01–p<0.001), 
respectively. The HDL content was also still significantly 
higher than that in the control group: when DAGO was 
administered – by 45.5% or when dynorphin A (1-13) 
was administered – by 45.5% (p<0.05). On the 7th day, 
the concentration of HDL in the groups treated with OPs 
was significantly higher than that in the control group 
(p<0.01-0.001).
Simulation of 2-hour swimming stress in Wistar rats 
caused increased levels of the following in plasma: of TC 
– by 25.7% (p<0.001), of NEFA – by 47.2% (p<0.01), of 
TG – by 19.6% (p<0.01), of LDL – by 77.8% (p<0.001), 
and of HDL – by 36.8% (p<0.01) –39 hours after the 
exposure (Table 7). On the 4th day of the experiment, 
the indicators returned back to normal. At the same 
time, though the content of HDL was reducing, it still 
remained significantly higher than that in the intact an-
imals (by 26.3%, p<0.01). On the 7th day, the concen-
tration of HDL remained 21.1% higher than that of the 
intact rats (p<0.05).
The injection of any of the studied OR agonists re-
duced the stress-induced changes in lipid metabolism in 
the animals which had been exposed to swimming stress. 
Dynorphin A (1-13) and DAGO had the most pronounced 
effect. There were no differences in the contents of TC, 
NEFA, TG, and LDL cholesterol in blood plasma between 
the stressed rats receiving one of these preparations and 
intact animals (p>0.05) when using these peptides as ear-
ly as 39 hours after the simulation of swimming stress.
Only DSLET resulted in an increase in HDL levels 
in blood plasma in the stressed rats compared those in 
with the control group. The concentration of HDL was 
65.4% higher (p <0.01) compared with that in the con-
trol group 39 hours after the exposure. The injection of 
neither DAGO nor dynorphin A (1-13) caused significant 
changes in HDL concentrations at all experimental peri-
ods compared with those in the control group.
Simulation of 12-day stress of limited mobility caused 
a statistically significant increase in the contents of TC, 
TG and NEFA (p<0.01–0.001) in plasma compared 
with those in the intact rats (by 70.2%, by 42.6% and by 
174.6%, respectively). The change in the contents of lipo-
proteins was multidirectional: whereas the concentrations 
of VLDL and LDL increased by 166.7% and 150%, re-
spectively, the content of HDL, by contrast, decreased by 
40.7% (p<0.01-0.001) (Table 8).
The use of Ops – DSLET or DAGO – caused a signifi-
cant decrease in the concentrations of TC, TG and NEFA. 
At the same time, the effect of DSLET was more pro-
nounced, which appeared in a decrease in the concentra-
tion of not only TC and NEFA, but also of TG (p<0.05).
The studied OPs did not significantly affect the con-
tents of LDL and VLDL in blood plasma of the rats that 
had been exposed to chronic stress (p>0.05). However, 
the concentration of HDL in plasma of the rats treated 
with peptides was significantly higher than that in plas-
ma of the control (p<0.01). However, no differences were 
found in the effects of individual opioids.
Thus, it was established that stress simulation was 
accompanied by an increase in the contents of TC, TG, 
NEFA, VLDL and LDL in blood plasma of rats, the se-
verity and duration of the increase depended on the se-
verity of the stress. Changes in HDL production depend-
ed on the severity of stress. Stress-limiting effect of OPs 
was accompanied by a decrease in the concentration of 
TC, TG, NEFA, VLDL and LDL, as well as an increase 
in the content of HDL. A more pronounced effect on 
stress-induced changes in lipid metabolism was provided 
by delta-OR agonist DSLET and kappa-OR agonist dy-
norphin A (1-13).
The data obtained show that in rats of the control 
group on the 1st day after resection of 70% of the liver, 
there was an increase in the mass of the right and caudate 
lobes by 20.8%, and the relative weight of the regener-
ating liver was 36.3% of the initial mass of the organ 
(before resection). On the 3rd, the mass of the two lobes 
remaining after resection increased by 128.7%, and the 
relative mass of the liver increased to 68.7%. On 7th day, 
the relative weight of the organ was 86.2% of the origi-
nal weight due to the active regeneration of the right and 
caudate lobes (by 187.3%).
The use of OPs had a stimulating effect on the regener-
ation of liver tissue after PHE. One day after resection, the 
mass of the right and caudate lobes increased by 53.3% 
in the group treated by DAGO, by 48.0% – in the group 
treated by dynorphin A (1-13), and by 38.3% – in the 
group treated by DSLET. These values were significant-
ly higher than the same indicators in the control group: 
when injecting DAGO – by 156.3% (p<0.001), dynorphin 
A (1-13) – by 130.8% (p<0.001), and DSLET – by 84.1% 
(p<0.05). In the groups of animals treated with OPs, there 
was also a significant increase in the relative weight of the 
organ: when injecting DAGO – by 46.0%, dynorphin A 
(1-13) – by 44.4%, and DSLET – by 41.5%. These indi-
cators were also significantly higher than those in the rats 
of the control group: when injecting DAGO – by 26.7% 
(p<0.001), dynorphin A (1-13) – by 22.3% (p<0.001), and 
DSLET – by 14.3% (p<0.05).
Three days after PHE in the groups of animals treat-
ed with dynorphin A (1-13) or DSLET, there was neither 
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statistically significant increase in the relative mass of 
the right and caudate lobes, nor in the relative mass of 
the liver. Only with the injection of DAGO, the relative 
mass index of the right and caudate lobes increased by 
25.6% (p<0.01). Accordingly, only in this group an in-
crease in the relative mass of the liver was noted – by 
14.2% (p<0.01).
On the 7th day of the experiment, in all the groups of 
rats that had undergone PHE and received OPs, there was 
a statistically significant increase in the relative weight 
of the right and caudate lobes, as well as in the relative 
weight of the liver. When using DAGO, the relative mass 
of the right and caudate lobes increased by 235.8%, which 
was 25.9% higher compared with that in the control group 
(p <0.001), when using dynorphin A (1-13) – by 278.2% 
(48.5% higher than that in the control group, p<0.001), 
when using DSLET – by 222.7% (18.9% higher than that 
in the control group, p<0.01). On the 7th day, a complete 
recovery of liver mass in the animals treated with DAGO 
was recorded. This indicator was 100.7%, which was 
16.8% higher than that in the control animals (p<0.001). 
In the group of rats treated with dynorphin A (1-13), there 
was a slight excess of the initial liver mass – 113.5%, 
which was 31.7% higher than that in the control animals 
(p<0.001). Only in the animals that had been treated with 
DSLET, the relative weight of the liver did not reach the 
initial level – 96.8%, but this was also significantly higher 
than that in the control group (by 12.3%, p<0.01).
Preliminary simulation of 12-day chronic stress for 
Wistar rats did not affect the regeneration of the rats’ liver 
after PHE. One day after resection, a stimulating effect 
of the immobilization stress was recorded on regenera-
tive processes in the liver after PHE: a more significant 
increase in the mass of the right and caudate lobes was 
found one day after surgery (by 187.5%, p<0.001) com-
pared with that in the non-stressed animals. The relative 
weight of the liver also increased significantly – by 32.0% 
(p<0.001). However, on the 3rd and 7th days, there were 
no statistically significant differences in both studied pa-
rameters (p>0.05) between the stressed and non-stressed 
animals that had undergone PHE according. The injection 
of DAGO to Wistar rats which had been exposed to stress 
and the subsequent 70% hepatectomy did not significant-
ly affect the regeneration processes in the liver at all the 
Table 7. The Effect of Opioid Peptides on the Content of Lipoproteins of Different Density in Blood Plasma of Rats at Different 
Periods of Swimming Stress Simulation (M±m, n=8).
Indicator
Group
Period after stress 
simulation
VLDL, mmol/L LDL, mmol/L HDL, mmol/L
Intact 0.08±0.01 0.09±0.01 0.19±0.01
Control (stressed) 39 hours 0.14±0.01 ххх 0.16±0.01ххх 0.26±0.01хх
4 days 0.12±0.01 0.11±0.01 0.24±0.02хх
7 days 0.09±0.01 0.10±0.01 0.23±0.02х
Stress+ DAGO at a 
dose of 6.3 mcg/kg
39 hours 0.12±0.01 0.12±0.01 0.31±0.02
4 days 0.13±0.01 0.11±0.01 0.25±0.01
7 days 0.12±0.01 0.11±0.01 0.27±0.02
Stress + DSLET at a 
dose of 10.0 mcg/kg
39 hours 0.11±0.01 0.13±0.02 0.43±0.03**
4 days 0.09±0.01 0.10±0.01 0.23±0.01
7 days 0.09±0.01 0.10±0.01 0.21±0.02
Stress + dynorphin 
A (1-13) at a dose of 
20.1 mcg/kg
39 hours 0.12±0.01*** 0.11±0.01*** 0.31±0.02
4 days 0.10±0.01 0.11±0.01 0.30±0.02
7 days 0.11±0.01 0.10±0.01 0.25±0.02
Note: x – p<0.05, xx – p<0.01, xxx – p<0.001 compared with intact animals. * – p<0.05, ** – p<0.01, *** – p<0.001 compared with 
control animals.
Table 8. The Effect of Opioid Peptides on the Content of Lipoproteins of Different Density in Blood Plasma of Rats at Different 
Periods of Chronic Stress Simulation (M±m, n=8).
Indicator
Group
VLD, mmol/L LDL, mmol/L HDL, mmol/L
Intact 0.06±0.01 0.06±0.01 0.27±0.02
Control (stressed) 0.16±0.01ххх 0.15±0.01ххх 0.16±0.01хх
Stress+ DAGO at a dose of 6.3 mcg/kg 0.13±0.01 0.14±0.01 0.34±0.04**
Stress + DSLET at a dose of 10.0 mcg/kg 0.14±0.01 0.14±0.01 0.35±0.05**
Stress + dynorphin A (1-13) at a dose of 20.1 mcg/kg 0.14±0.01 0.14±0.01 0.33±0.04**
Note: x – p<0.05, xx – p<0.01, xxx – p<0.001 compared with intact animals. * – p<0.05, ** – p<0.01, *** – p<0.001 compared with 
control animals.
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periods of observation. The use of dynorphin A (1-13) had 
a stimulating effect on liver regeneration only on the 7th 
day of the experiment. During that period, recovery of the 
liver mass was observed (100.3% of the initial mass of 
the organ) and the relative weight of the liver was statis-
tically significantly higher than that in the rats of the con-
trol group (by 11.7%, p<0.001). The injection of DSLET 
caused an increase in the studied indicators in the stressed 
rats only on the 1st day of the experiment. For instance, 
the relative increase in the mass of the right and caudate 
lobes turned out to be 47.5% higher than that in the con-
trol group (p<0.05), and the relative mass of the liver was 
22.3% higher (p<0.01).
Simulation of 70% hepatectomy caused an increase in 
the activities of ALT, AST and LDH in blood plasma on 
the 1st day after surgery by 120.5%, 59.8% and 76.0%, 
respectively (p<0.001) (Table 9). On the 3rd day after sur-
gery, the activities of ALT and AST increased compared 
to those on the first day of observation and remained sig-
nificantly higher than such indicators in the intact rats 
(p<0.001). The activity of LDH was 65.2% higher than 
that in the intact animals (p<0.001). During this period, 
the disorders of the protein-synthetic function of the liv-
er were observed, which was manifested by a decrease 
in the concentrations of total protein (by 7.0%, p<0.01) 
and albumin (by 11.3%, p<0.001). There was a 26.6% in-
crease in total bilirubin in blood plasma (p<0.001). ALT, 
AST and LDH activities in the control animals were still 
higher than those in the intact rats (by 80.1%, 29.2% and 
26.4%, respectively, p<0.05-0.001) on the 7th day after re-
section. The concentrations of total protein and albumin 
were lower than those in the animals of the intact group 
(by 5.3% and 15.5%, respectively, p<0.05-0.001). There 
were no differences between the levels of total bilirubin 
in plasma of the animals of the control and intact groups 
7 days after surgery.
The injection of the studied OPs did not affect the indi-
cators of cytolytic syndrome, protein-synthetic and detox-
ification functions of the liver in animals which had under-
gone 70% liver resection on the first day after surgery. On 
the 3rd day, the peptides exhibited their hepatoprotective 
effect. So, in the rats that were injected with dynorphin A 
(1-13), the activities of ALT, AST and LDG were lower 
by 32.5%, 7.3% and 18.3%, respectively (p<0.05-0.001) 
compared with those in the control group, when using 
DAGO – by 29.9%, 9.0% and 21.8% lower (p<0.05-
0.001), and when using DSLET - by 28.4%, 11.0% and 
21.4% lower, respectively (p<0.05-0.001). An increase 
in the concentration of total protein by 2.9%, 3.2% and 
3.0% in the rats treated by dynorphin A (1-13), DAGO 
and DSLET, respectively, was also found (p<0.05). There 
was a decrease in the level of total bilirubin in blood 
plasma on the 3rd day after liver resection when using dy-
norphin A (1-13), DAGO and DSLET – by 6.0%, 11.0% 
and 6.0%, respectively (p<0.05). In the group of animals 
which had undergone liver resection, administration of 
dynorphin A (1-13) caused a decrease in the activities of 
ALT, AST, LDG by 32.8%, 27.0% and 18.3%, respective-
ly, compared to those in the control group 7 days after 
surgery (p<0.001). An increase in the concentrations of 
total protein (by 5.8%, p<0.01) and albumin (by 8.4%, 
p<0.01) indicates an increase in the protein-synthetic 
function of the liver under the influence of the peptide. 
The injection of DAGO decreased the activities of ALT, 
AST and LDH by 33.7%, 25.6% and 20.3%, respectively, 
compared to those in the control group (p<0.001). There 
was an increase in the contents of total protein and al-
bumin by 6.9% (p<0.001) and 13.0% (p<0.001), respec-
tively. A similar effect resulted from the use of DSLET. 
The injection of this peptide decreased ALT activity by 
35.2% (p<0.001), AST – by 29.0% (p<0.001), and LDG – 
by 22.6% (p<0.001). An increase in the total protein con-
tent (by 6.6%, p<0.001) and albumin content (by 12.6%, 
p<0.001) was also observed. The study showed that the 
preliminary simulation of long-term stress did not affect 
the changes in the activities of ALT, AST and LDG, the 
concentrations of total protein, albumin and total biliru-
bin in the animals that had undergone PHE throughout 
the experiment compared with the non-stressed rats. Of 
all the OPs used in the study, only DAGO showed a cy-
toprotective effect in stressed rats which had undergone 
PHE, which was manifested by a decrease in the activity 
of the following in blood plasma on the 4th day after the 
operation: of ALT – by 20.6% (p <0.05), of AST – by 8.0 
% (p<0.05), and of LDG – by 28.6% (p<0.01). On the 7th 
day after PHE, the activities of ALT and LDG in plasma 
of rats that had undergone resection and had been treated 
with DAGO was lower by 28.8% and 17.4%, respective-
ly, compared with those in the non-stressed rats after PHE 
treated with DAGO.
The obtained results confirm the literature data on the 
nearly complete recovery of the liver mass after 70% 
hepatectomy in rats after 7–10 days (in the control group, 
the relative weight of the liver was 86.2%). The use of 
OPs had a stimulating effect on the regeneration of the 
liver after PHE. The most pronounced effect was shown 
by the selective kappa-OR agonist dynorphin A (1-13) 
and the selective mu-OR agonist DAGO. As early as one 
day after PHE, the relative weight of the liver in the rats 
treated with OPs was significantly higher than that in the 
animals of the control group. A more pronounced stimu-
lating effect of DAGO appeared on the 3rd day after sur-
gery. It was in the rats treated with this peptide, where 
there was an increase in the relative weight of the liver 
and the relative weight of the right and caudate lobes. The 
stimulating effect of dynorphin A (1-13) was most pro-
nounced on the 7th day of the experiment, when the rela-
tive weight of the liver in the rats receiving it was 113.5%. 
In the group of animals treated with DAGO, the restora-
tion of the initial mass of the liver was also observed, and 
in the rats that were injected with DSLET the restoration 
was nearly complete.
It is known that the process of liver regeneration af-
ter PHE is controlled by a whole cascade of growth fac-
tors, cytokines, transcription factors; however, the most 
important of them are hepatocyte growth factor (HGF), 
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epidermal growth factor, transforming growth factor al-
pha, and angiogenic factors (Alvarado et al. 2016, Beier 
et al. 2016, E et al. 2017, Ibis et al. 2017, Kirschbaum 
et al. 2017, Lisman and Porte 2016). Hepatocyte growth 
factor plays a key role because it induces the transition of 
hepatocytes to the mitotic phase. In an inactive state, it 
is present in the liver tissue matrix in significant quanti-
ties, and after hepatectomy, under the influence of uroki-
nase and the enzymes of the metalloprotease family, HGF 
gets activated and triggers the division of hepatocytes. Of 
interest if the fact that the epidermal growth factor acts 
mainly at the initial stage of liver regeneration, while the 
transforming growth factor alpha – at later stages (Fausto 
et al. 2012, Adamek et al. 2017).
It is assumed in this study that the stimulating effect 
of OPs on liver regeneration after PHE is associated with 
their effect on the cytokine cascade, which leads to either 
an increase in the concentration of active HGF in liver 
tissue or to acceleration of its activation, which leads to 
the early onset of mitotic division of the remaining cells. 
DAGO has the greatest effect, which is why its stimulat-
ing effect is observed at all periods of observation. Dynor-
phin A (1-13) can activate the release of a transforming 
growth factor alpha more than other OPs, therefore its 
activating effect on the regeneration of the liver is most 
pronounced at the final stage (on the 7th day).
Simulation of 12-day chronic limited mobility stress 
in rats caused activation of the liver tissue regeneration 
process on the first day after 70% hepatectomy. Further 
- on the 3rd and 7th days after resection, this effect is not 
observed. There were no changes in the functional activ-
ity of the liver.
It is assumed in this study that this is due to the fact that 
along with stress-induced lesions of hepatocytes, there is 
activation of regenerative processes in the liver tissue af-
ter stress. That is, there is activation of hepatocyte growth 
factor and mitotic cell division. Therefore, surviving 
hepatocytes begin to divide faster after 70% of hepatecto-
my, against the background of a high level of active HGF.
When conducting a factor analysis, simulation of 
3-hour acute stress led after 39 hours to the formation of 
3 factors. The first factor, having the largest share of the 
total variance of the factor and a large share of the total 
variance, included the following indicators: contents of 
MDA and total protein in plasma had a positive factor 
load, AST activity and AHP concentration in plasma, as 
well as catalase and SOD activities in the liver had a neg-
ative factor load. The second factor included indicators 
characterizing the contents of HDL, TG and VLDL. The 
third factor included correlated indicators of SOD and 
catalase activities in plasma.
As the stress load increased, the factor load included 
lipid and protein metabolism indicators. So with a 6-hour 
immobilization stress, 39 hours after stress simulation, 
the first factor included indicators of catalase activity and 
the concentration of AHP in plasma with a positive load 
and the contents of VLDL and HDL with a negative one. 
The second factor included the contents of total protein, 
albumin in plasma and contents of TG, LDL, and NEFA. 
During other periods of observation, the factor load did 
not change significantly. After simulating the 12-hour im-
mobilization stress, the first factor included the positive 
load indicators – LDL, VLDL, plasma albumin content 
and the negative load — MDA and AGP concentrations in 
plasma. By the 7th day, the factor structure changed, and 
the first factor included the indicators of the levels of TG, 
HDL, catalase activity in plasma and liver tissue, ALT ac-
tivity, MDA concentration in liver tissue and blood plas-
ma. These changes can indicate the activation of lipolysis 
and LPO, as the leading processes under stress. The in-
jection of all OPs changed the factor load. At the same 
time, the structure of factors was more pronounced with 
the injection of DSLET or dynorphin A (1-13).
Table 9. The Effect of PHE on the Activity of ALT, AST and LDH in Blood Plasma of Rats (M±m, n=8).
Indicator
Group






Intact 52.3±3.7 195.7±13.3 244.3±4.8
Control (stressed) 1 days 115.3±5.5ххх 312.7±8.1 ххх 430.0±17.2 ххх
3 days 133.3±5.6 ххх 342.7±8.8 ххх 403.7±10.4 ххх
7 days 94.2±5.5 ххх 252.8±10.8 х 308.7±7.2 х
Stress+ DAGO at a 
dose of 6.3 mcg/kg
1 days 98.7±5.6 300.2±8.5 432.0±8.6
3 days 93.5±5.0*** 311.8±7.0* 315.7±7.2***
7 days 62.5±2.9*** 188.0±6.9*** 246.0±6.7***
Stress + DSLET at a 
dose of 10.0 mcg/kg
1 days 100.2±7.3 289.5±11.5 418.3±10.0
3 days 95.5±3.6*** 309.0±10.1* 317.2±13.6***
7 days 61.0±3.3*** 179.5±4.4*** 238.8±5.4***
Stress + dynorphin 
A (1-13) at a dose of 
20.1 mcg/kg
1 days 103.2±5.6 284.0±10.7 414.7±10.00
3 days 90.0±3.9*** 317.5±6.5* 329.7±10.9**
7 days 63.3±3.0*** 184.5±6.0*** 252.2±7.8***
Note: x – p<0.05, xx – p<0.01, xxx – p<0.001 compared with intact animals. * – p<0.05, ** – p<0.01, *** – p<0.001 compared with 
control animals.
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When simulating chronic stress, the first factor includ-
ed the indicators of catalase activity in plasma, the con-
tent of AHP in plasma and liver tissue, the activity of SOD 
in plasma, the contents of VLDL and NEFA. A similar 
factor structure was with the administration of dynorphin 
A (1-13) and DSLET. With the administration of DAGO, 
the first factor included the indicators of TG content, the 
contents of MDA and HDL in blood plasma.
The structure of the factors during swimming stress 
includes only the indicators of LPO in plasma and liver 
tissue, protein and glucose concentrations, which indi-
cates the activation of the processes in muscles. By the 
7th day, the factor structure of activated lipolysis could be 
observed, whish is similar to acute stress. With the ad-
ministration of DAGO, the structure of factors for all the 
periods of the study mainly included the correlated indi-
cators of LPO in blood plasma and liver tissue, as well as 
lipid metabolism. Changes in the factor structure with the 
administration of DSLET and dynorphin A (1-13) were 
characterized by a greater divergence of the indicators in-
cluded in the factor structure.
Conclusion
The obtained results confirm the literature data on the pre-
sence of phase changes in the liver after immobilization 
stress, depending on the stage of the stress reaction (Ivan-
ov 1998). The data of the present study confirm the deve-
lopment of dystrophic changes in hepatocytes and impai-
red intrahepatic microcirculation. The study confirms the 
early onset of reparative processes in the liver after stress: 
after 39 hours, the number of binuclear cells and hepato-
cytes containing more than one nucleolus increases signi-
ficantly in animals that were exposed to immobilization. 
Stress exposure leads to the development of a complex of 
structural changes in the liver, indicating the formation of 
an adaptive response. Moreover, it should be noted that 
this process is realized in the conditions of limited possi-
bilities of its plastic provision, since the general direction 
of metabolic processes is characterized by predominating 
catabolism (Shkurupij 1989).
The development of dystrophic changes in hepatocytes 
is associated with the action of high concentrations of 
catecholamines (Klimov and Nikulcheva 1995), causing 
impaired intrahepatic microcirculation, hypoxia, and acti-
vation of lipid peroxidation.
The presented data confirm the fact that a degree of 
stress-induced disturbances in hepatocytes increases only 
as long as a certain strength of the stimulus is reached, its 
further increase is not accompanied by the worsening of 
the process manifestations.
Simulation of acute 6- or 12-hour stress was accom-
panied by a decrease in plasma protein levels as early as 
39 hours after the exposure. It is assumed in this study 
that such a change is accounted for, first of all, by the 
activation of proteolysis in the initial period of the exper-
iment. Impairment of the protein-synthetic function of the 
liver occurs later, on the 4th day after the exposure, when 
the concentration of albumin in the blood decreases. The 
chronic effect of the stress factor leads to a decrease in the 
content of albumin and protein in blood plasma. In this 
case, such changes are primarily associated with inhibi-
tion of the protein-synthetic function of the liver.
An increase in TC and NEFA contents in plasma in 
stress is a typical change, which is due to increased tri-
glyceride mobilization and NEFA esterification in adi-
pose tissue under the influence of adrenaline (Trilis et al. 
2006). A similar effect is due to the activation of adenylate 
cyclase by catecholamines released under stress, which 
provides a shift of the metabolism from carbohydrates to 
lipids (Hulbert et al. 2005). An increase in TC in plasma 
is associated with the inhibition of the key enzyme of cho-
lesterol catabolism – 7-alpha hydroxylase (Klimov 1992) 
by LPO products, which are accumulated during stress. 
Earlier it was shown that an increase of NEFA concentra-
tion in blood leads to increased formation of LDLs (Trilis 
et al. 2006).
An insignificant increase in the contents of TC and 
NEFA under the influence of swimming stress in com-
parison with immobilization stress is noteworthy. It is as-
sumed in this study that this can be explained by the fact 
that intense exercise during swimming is accompanied 
by active consumption of lipolysis products, although the 
2-hour swimming stress compared with a 6-hour immo-
bilization stress may be characterized by a shorter and 
stronger effect of the stress factor.
As early as 39 hours after the exposure to a 3-hour 
immobilization stress or after intensive swimming, there 
is an increase in the formation of HDL, which indicates 
a high functional activity of hepatocytes. The trigger 
of HDL hyperproduction can be moderate activation of 
LPO, as it is known that HDLs have a pronounced antiox-
idant effect (Bueverov 2002).
On the contrary, a decrease in the concentration of 
HDLs in plasma may reflect the inhibition of the functional 
activity of hepatocytes under the influence of severe stress. 
The accumulation of LPO products has also a depressant 
effect on the formation of HDLs (Bueverov 2002).
Currently, there is no doubt about the leading role of 
impaired prooxidant-antioxidant balance and activation 
of lipid peroxidation in the development of stress-in-
duced lesions of various organs (Lishmanov and Maslov 
1994). Numerous literature data confirm the fact that ex-
posure to an extreme irritant causes structural and func-
tional abnormalities in the liver (Ivanov 1998). In par-
ticular, microcirculation abnormalities develop, which 
lead to hypoxia of hepatocytes and intensification of LPO 
processes with subsequent damage to mitochondria and 
necrosis of liver cells (Simonenkov and Fedorov 2008). 
On the basis of the results obtained, it can be concluded 
that the action of a moderately strong stressor stimulates 
SOD and catalase activities, and its long-term action, on 
the contrary, causes inhibition of enzyme activity, both in 
blood plasma and in liver tissue. It is known that the main 
function of SOD is the destruction of the superoxide an-
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ion radical, which is formed in excess when free radical 
oxidation is activated. The superoxide anion radical not 
only causes damage to cellular structures, but also inter-
acts with hydrogen peroxide in the Haber-Weiss reaction, 
which results in the formation of one of the most reactive 
oxygen forms, the hydroxyl radical. In the experiments 
of the present study, an increase in SOD activity during 
short immobilization is an important adaptive factor that 
reduces the concentration of superoxide anion radical. A 
decrease in SOD activity in liver tissue during swimming 
stress indicates a drop in the potential of antioxidant sys-
tems, which counteracts the activation of free radical ox-
idation. A decrease in SOD activity in the liver tissue may 
be associated with the accumulation of oxidized metabol-
ic products in the rats under conditions of intense phys-
ical exertion. A simultaneous increase in SOD activity 
in plasma can be explained by increased activity of this 
enzyme in other organs and tissues, which, among other 
things, secrete it into blood. The increased activity of cat-
alase in the liver reflects the general direction of changes 
in the activity of antioxidant enzymes with a short action 
of an extraordinary factor.
A decrease in the activities of both SOD and catalase, 
both in plasma and in liver tissue in the course of simulat-
ed chronic stress, confirms the conclusion that the activity 
of antioxidant enzymes is inhibited during prolonged ex-
posure to a stress factor. It was previously shown that the 
suppression of catalase activity is observed at the time of 
prolonged immobilization, which is due to the inhibitory 
effect of excessive concentrations of MDA and AGP, as 
well as possible structural changes in the enzyme mol-
ecule as a result of its glycation (Zor’kina et al. 1997). 
It is established that a low level of catalase enhances a 
toxic effect of lipid peroxidation products (Zborovskaja 
and Bannikova 1995). However, LPO cannot be consid-
ered solely as a mechanism of damage. At present, a large 
amount of information has been accumulated confirming 
the fact that free radicals are secondary messengers and, 
thus, are involved in the regulation of various functions of 
the body (Dubinina 2001).
The present study makes it possible to make a con-
clusion about the hepatoprotective effect of OPs during 
stress, which is manifested by a decrease in dystrophic 
and microcirculatory abnormalities in the liver tissue. 
A comparative study of the effect of selective OR ago-
nists in equimolar doses on morphological and func-
tional changes in the liver tissue during acute or chronic 
immobilization stress shows that the most pronounced 
hepatoprotective effect is observed when activating the 
dynorphinergic link of EOS. The high stress-protective 
activity of dynorphin A (1-13) in the liver tissue is ex-
plained, apparently, by the significant presence of kappa 
receptors in this organ, as well as the peculiarities of OP 
metabolism under the influence of specific and nonspecif-
ic peptidases (Panchenko et al. 1999). In the simulation 
of swimming stress, a selective mu-OR agonist DAGO 
had the strongest hepatoprotective effects. It is assumed in 
this study that these differences are explained by the pe-
culiarities of metabolic processes during intensive swim-
ming. Physican exercise, as known, is accompanied by 
the accumulation of non-oxidized products in the muscle 
tissue, which undergo further metabolic transformations 
in the liver. Apparently, the intense effect of non-oxidized 
products changes the sensitivity of different types of OR 
toward selective agonists, increasing the activity, first of 
all, of mu-OR.
This indicates the peculiarities of the implementation 
of the stress-protective effect of the components of the 
Figure 5. The mechanism of the hepatoprotective effect of OPs under stress.
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stress-limiting system under various types of stress. It 
was established that the hepatoprotective effect of opi-
oids was more pronounced in stress-susceptible animals, 
which were characterized by insufficiency of stress-lim-
iting systems, when comparing the effects of OPs in an-
imals of various typological groups. The mechanism of 
the hepatoprotective effect of OPs under stress includes 
the correction of the prooxidant-antioxidant balance, the 
stimulation of adaptation processes in the system of anti-
oxidant enzymes, the cytoprotective effect and the correc-
tion of microcirculation abnormalities in the liver tissue 
under stress (Fig. 5). High catalase activity in the animals 
treated with dynorphin A (1–13) is noteworthy, since the 
prevention of excessive formation of hydrogen peroxide 
significantly reduces the toxic effect of LPO activation 
(Lishmanov and Maslov 1994). The high activity of SOD 
in the liver tissue in the rats treated by dynorphin A (1-13) 
is associated with a relatively low content of MDA, and, 
consequently, a decrease in its toxic effect on the enzyme.
Opioids have been shown to prevent stress-induced li-
pid metabolism disorders, and no specific effects of indi-
vidual selective OR agonists have been detected.
Of interest is the fact established in the paper about the 
stimulating effect of chronic stress on liver regeneration 
in the initial period of this process.
In experiments with PHE simulation, it was shown 
that all the studied opioids stimulated the regeneration 
of liver tissue, and selective kappa-OR agonists dy-
norphin A (1-13) and mu-OR DAGO showed the most 
pronounced effect. It is assumed in this study that the 
stimulating effect of OPs on the regeneration of liver tis-
sue after PHE may be explained by the activation of the 
formation of the necessary growth factors, in particular, 
the key component of the cascade, the hepatocyte growth 
factor. The action of opioids is accompanied either by 
an increase in the synthesis of hepatocyte growth fac-
tor in the liver tissue, or by its faster activation, which 
leads to an acceleration of the mitotic division of the re-
maining cells. DAGO has the most pronounced similar 
effect, which is why its stimulating effect was observed 
throughout all periods of the study. Dynorphin A (1-13) 
can activate the release of a transforming growth factor 
alpha more than other OPs, therefore its activating effect 
on the regeneration of the liver is most pronounced at the 
final stage (on the 7th day).
Thus, the findings of the present study reveal the mech-
anisms of participation of the endogenous opioid system 
in the prevention of liver damage in stress, and open up 
prospects for the use of pathogenetic therapy based on OP 
analogues in stress-induced liver damage, as well as other 
forms of its pathology.
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